BioArctic receives Orphan Drug Designation for exidavnemab the US
07.08.2025 - 18:03:56 | prnewswire.co.uk
View original content:https://www.prnewswire.co.uk/news-releases/bioarctic-receives-orphan-drug-designation-for-exidavnemab-the-us-302403441.html
en | boerse | 67991098 |
